241 related articles for article (PubMed ID: 14521905)
1. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
Noh EJ; Lee JS
Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
[TBL] [Abstract][Full Text] [Related]
2. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
Noh EJ; Lim DS; Jeong G; Lee JS
Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Hiranabe-Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Ann N Y Acad Sci; 1999; 886():195-9. PubMed ID: 10667218
[TBL] [Abstract][Full Text] [Related]
6. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
9. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity.
Blagosklonny MV; Robey R; Sackett DL; Du L; Traganos F; Darzynkiewicz Z; Fojo T; Bates SE
Mol Cancer Ther; 2002 Sep; 1(11):937-41. PubMed ID: 12481415
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
13. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A.
Katula KS; Fields A; Apple P; Rotruck T
Arch Biochem Biophys; 2002 May; 401(2):271-6. PubMed ID: 12054478
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
Ju R; Muller MT
Cancer Res; 2003 Jun; 63(11):2891-7. PubMed ID: 12782595
[TBL] [Abstract][Full Text] [Related]
17. Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
Flørenes VA; Skrede M; Jørgensen K; Nesland JM
Melanoma Res; 2004 Jun; 14(3):173-81. PubMed ID: 15179185
[TBL] [Abstract][Full Text] [Related]
18. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.
Gui CY; Ngo L; Xu WS; Richon VM; Marks PA
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1241-6. PubMed ID: 14734806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
